We are live on ! Find out more
VM

Valor Management Portfolio holdings

AUM $181M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
-0.19%
1 Year Est. Return
+6.67%
3 Year Est. Return
+15.4%
5 Year Est. Return
10 Year Est. Return
AUM
$67.3M
AUM Growth
-$171M
Cap. Flow
-$184M
Cap. Flow %
-273.69%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HRMY icon
Harmony Biosciences
HRMY
+$184M

Sector Composition

Rank Sector Weight
1 Healthcare 99.1%
2 Consumer Discretionary 0.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRMY icon
1
Harmony Biosciences
HRMY
$2.04B
$35M 51.91%
1,268,204
-5,349,829
-81% -$184M
BWAY
2
Brainsway
BWAY
$611M
$31.7M 47.08%
4,207,490
SOND
3
DELISTED
Sonder
SOND
$605K 0.9%
476,321
BIOA
4
BioAge Labs
BIOA
$402M
$77.1K 0.11%
13,105

Similar funds

Valor Management's Q3 2025 Portfolio in Review

As of Q3 2025, Valor Management held 4 positions worth $67.3M, down 72% from $238M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Valor Management withdrew a net $184M in Q3 2025, reducing 1 holding. Its largest reduction was Harmony Biosciences, cutting an estimated $184M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier, followed by Consumer Discretionary.

  • Valor Management's biggest Q3 2025 reduction was Harmony Biosciences, cutting an estimated $184M.
  • Valor Management's ten largest holdings make up 100% of its $67.3M portfolio in Q3 2025.
  • Valor Management opened 0 new positions and closed 0 in Q3 2025.
  • Valor Management's portfolio value fell 72% quarter-over-quarter to $67.3M.

Based on Valor Management's 13F filing for Q3 2025, filed 14 Nov 2025.